In vitro and in vivo anticancer properties of cucurbitacin isolated from Cayaponia racemosa

References

• Abd El-Fattah H. (1994). Structure revision of cucurbitacin Q1. Phytochemistry, 36, 159–161.
   Google Scholar
• Attard E, Brincat MP, Cuschieri A. (2005). Immunomodulatory activity of cucurbitacin E isolated from Ecballium elaterium. Fitoterapia, 76, 439–441.
   PubMed Web of Science ®Google Scholar
• Bezerra DP, de Castro FO, Alves AP, Pessoa C, de Moraes MO, Silveira ER, Lima MA, Elmiro FJ, de Alencar NM, Mesquita RO, Lima MW, Costa-Lotufo LV. (2008). In vitro and in vivo antitumor effect of 5-FU combined with piplartine and piperine. J Appl Toxicol, 28, 156–163.
   PubMed Web of Science ®Google Scholar
• Blaskovich MA, Sun J, Cantor A, Turkson J, Jove R, Sebti SM. (2003). Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res, 63, 1270–1279.
   PubMed Web of Science ®Google Scholar
• Chan KT, Li K, Liu SL, Chu KH, Toh M, Xie WD. (2010a). Cucurbitacin B inhibits STAT3 and the Raf/MEK/ERK pathway in leukemia cell line K562. Cancer Lett, 289, 46–52.
   PubMed Web of Science ®Google Scholar
• Chan KT, Meng FY, Li Q, Ho CY, Lam TS, To Y, Lee WH, Li M, Chu KH, Toh M. (2010b). Cucurbitacin B induces apoptosis and S phase cell cycle arrest in BEL-7402 human hepatocellular carcinoma cells and is effective via oral administration. Cancer Lett, 294, 118–124.
   PubMed Web of Science ®Google Scholar
• Chen JC, Chiu MH, Nie RL, Cordell GA, Qiu SX. (2005). Cucurbitacins and cucurbitane glycosides: Structures and biological activities. Nat Prod Rep, 22, 386–399.
   PubMed Web of Science ®Google Scholar
• Cragg GM, Newman DJ. (2005). Plants as a source of anti-cancer agents. J Ethnopharmacol, 100, 72–79.
   PubMed Web of Science ®Google Scholar
• Cury-Boaventura MF, Pompéia C, Curi R. (2004). Comparative toxicity of oleic acid and linoleic acid on Jurkat cells. Clin Nutr, 23, 721–732.
   PubMed Web of Science ®Google Scholar
• Dantas IN, Gadelha GC, Chaves DC, Monte FJ, Pessoa C, de Moraes MO, Costa-Lotufo LV. (2006). Studies on the cytotoxicity of cucurbitacins isolated from Cayaponia racemosa (Cucurbitaceae). Z Naturforsch, C, J Biosci, 61, 643–646.
   PubMedGoogle Scholar
• Doskotch RW, Malik MY, Beal JL. (1969). Cucurbitacin B, the cytotoxic principle of Begonia tuberhybrida var. alba. Lloydia, 32, 115–122.
   PubMedGoogle Scholar
• Duncan KL, Duncan MD, Alley MC, Sausville EA. (1996). Cucurbitacin E-induced disruption of the actin and vimentin cytoskeleton in prostate carcinoma cells. Biochem Pharmacol, 52, 1553–1560.
   PubMed Web of Science ®Google Scholar
• Fang X, Phoebe CH Jr, Pezzuto JM, Fong HH, Farnsworth NR, Yellin B, Hecht SM. (1984). Plant anticancer agents, XXXIV. Cucurbitacins from Elaeocarpus dolichostylus. J Nat Prod, 47, 988–993.
   PubMed Web of Science ®Google Scholar
• Ferreira PM, Santos AG, Tininis AG, Costa PM, Cavalheiro AJ, Bolzani VS, Moraes MO, Costa-Lotufo LV, Montenegro RC, Pessoa C. (2010). Casearin X exhibits cytotoxic effects in leukemia cells triggered by apoptosis. Chem Biol Interact, 188, 497–504.
   PubMedGoogle Scholar
• Imboden JB. (1988). The regulation of intracellular signals during lymphocyte activation. Immunol Today, 9, 17–18.
   PubMedGoogle Scholar
• Jayaprakasam B, Seeram NP, Nair MG. (2003). Anticancer and antiinflammatory activities of cucurbitacins from Cucurbita andreana. Cancer Lett, 189, 11–16.
   PubMed Web of Science ®Google Scholar
• Kumar V, Abbas AK, Fausto N, Robbins SL, Cotran RS. (2004). Pathology Basis of Disease. China: WB Saunders.
   Google Scholar
• Leist M, Jäättelä M. (2001). Four deaths and a funeral: From caspases to alternative mechanisms. Nat Rev Mol Cell Biol, 2, 589–598.
   PubMed Web of Science ®Google Scholar
• Liu T, Zhang M, Zhang H, Sun C, Deng Y. (2008). Inhibitory effects of cucurbitacin B on laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol, 265, 1225–1232.
   PubMedGoogle Scholar
• Magalhães HI, Ferreira PM, Moura ES, Torres MR, Alves AP, Pessoa OD, Costa-Lotufo LV, Moraes MO, Pessoa C. (2010). In vitro and in vivo antiproliferative activity of Calotropis procera stem extracts. An Acad Bras Cienc, 82, 407–416.
   PubMedGoogle Scholar
• Militão GC, Dantas IN, Pessoa C, Falcão MJ, Silveira ER, Lima MA, Curi R, Lima T, Moraes MO, Costa-Lotufo LV. (2006). Induction of apoptosis by pterocarpans from Platymiscium floribundum in HL-60 human leukemia cells. Life Sci, 78, 2409–2417.
   PubMedGoogle Scholar
• Musza LL, Speight P, McElhiney S, Barrow CJ, Gillum AM, Cooper R, Killar LM. (1994). Cucurbitacins, cell adhesion inhibitors from Conobea scoparioides. J Nat Prod, 57, 1498–1502.
   PubMedGoogle Scholar
• Sato DY, Wal R, de Oliveira CC, Cattaneo RI, Malvezzi M, Gabardo J, Buchi Dde F. (2005). Histopathological and immunophenotyping studies on normal and sarcoma 180-bearing mice treated with a complex homeopathic medication. Homeopathy, 94, 26–32.
   PubMedGoogle Scholar
• Scheuer PJ, Lefkowitch JH . (2000). Liver Biopsy Interpretation. England: WB Saunders.
   Google Scholar
• Shan XL, Zhou XY, Yang J, Wang YL, Deng YH, Zhang MX. (2010). [Inhibitory effect of cucurbitacin E on the proliferation of ovarian cancer cells and its mechanism]. Chin J Cancer, 29, 20–24.
   PubMedGoogle Scholar
• Shi X, Franko B, Frantz C, Amin HM, Lai R. (2006). JSI-124 (cucurbitacin I) inhibits Janus kinase-3/signal transducer and activator of transcription-3 signalling, downregulates nucleophosmin-anaplastic lymphoma kinase (ALK), and induces apoptosis in ALK-positive anaplastic large cell lymphoma cells. Br J Haematol, 135, 26–32.
   PubMed Web of Science ®Google Scholar
• Smit HF, van den Berg AJ, Kroes BH, Beukelman CJ, Quarles van Ufford HC, van Dijk H, Labadie RP. (2000). Inhibition of T-lymphocyte proliferation by cucurbitacins from Picrorhiza scrophulariaeflora. J Nat Prod, 63, 1300–1302.
   PubMed Web of Science ®Google Scholar
• Stuppner H, Muller EP, Wagner H. (1981). Cucurbitacins from Picrorhiza kurooa. Phytochemistry, 30, 305–310.
   Google Scholar
• Sun C, Zhang M, Shan X, Zhou X, Yang J, Wang Y, Li-Ling J, Deng Y. (2010). Inhibitory effect of cucurbitacin E on pancreatic cancer cells growth via STAT3 signaling. J Cancer Res Clin Oncol, 136, 603–610.
   PubMed Web of Science ®Google Scholar
• Wakimoto N, Yin D, O’Kelly J, Haritunians T, Karlan B, Said J, Xing H, Koeffler HP. (2008). Cucurbitacin B has a potent antiproliferative effect on breast cancer cells in vitro and in vivo. Cancer Sci, 99, 1793–1797.
   PubMed Web of Science ®Google Scholar
• Yasuda S, Yogosawa S, Izutani Y, Nakamura Y, Watanabe H, Sakai T. (2010). Cucurbitacin B induces G2 arrest and apoptosis via a reactive oxygen species-dependent mechanism in human colon adenocarcinoma SW480 cells. Mol Nutr Food Res, 54, 559–565.
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhang H, Sun C, Shan X, Yang X, Li-Ling J, Deng Y. (2009). Targeted constitutive activation of signal transducer and activator of transcription 3 in human hepatocellular carcinoma cells by cucurbitacin B. Cancer Chemother Pharmacol, 63, 635–642.
   PubMedGoogle Scholar